Using Artificial Intelligence in Drug Discovery & Development for Diseases of Aging: Opportunities & Considerations

Time: 4:15 pm
day: Day Two


  • Building classification models for diseases of aging
  • Evaluating the use of AI for unbiased drug screening
  • Discussing the potential of AI in drug development for aging diseases beyond discovery